Clinical Trials for Parkinson's Dyskinesia
Dyskinesia is the involuntary, dance-like movement that often shows up after years of levodopa treatment. It is one of the most disruptive long-term side effects of standard Parkinson's care, and a meaningful share of current research is focused on managing or preventing it.
Trials in this area study new medications designed to reduce dyskinesia, smarter levodopa formulations meant to keep blood levels steadier, and devices that deliver medication more consistently.
Below are the recruiting trials we track that focus on dyskinesia. Sign up to be emailed when a new one opens.
11 Recruiting Dyskinesia Trials
- Improve trunk posture and balance, NCT07610031, RECRUITING
- Personalize brain stimulation for movement, NCT07398157, RECRUITING
- Reduce wearing off between doses, NCT07432958, PHASE2, RECRUITING
- Measure tremor and involuntary movements, NCT06490861, RECRUITING
- Improve balance using telerehabilitation games, NCT05773885, RECRUITING
- Detect subtle walking changes early, NCT06907589, RECRUITING
- Validate scale measuring involuntary movements, NCT07023224, RECRUITING
- Identify serotonin abnormalities causing pain, NCT06008704, RECRUITING
- Reduce forward and sideways leaning, NCT07010328, RECRUITING
- Reduce tremor and involuntary movements, NCT05626608, RECRUITING
- Delay and reduce involuntary movements, NCT06570824, RECRUITING